Panacea Life Sciences and Benivita Launch Benivita PLSH to Expand Virtual Health Benefits
Panacea Life Sciences Holdings Inc. has announced the launch of Benivita PLSH, a new joint venture with Benivita Inc., aimed at transforming access to non-insurance benefits, virtual telemedicine services, and wellness programs across the United States. Through this partnership, Panacea Life Sciences Holdings will own 100% of Benivita PLSH, providing initial operating capital and issuing restricted common shares to Benivita Inc. The platform will leverage PLSH's infrastructure, Benivita's expertise in direct and multi-level marketing, and New Benefits Inc.'s leadership in benefit aggregation. Benivita PLSH will offer individuals and families direct access to benefit networks typically reserved for corporate employees, with a focus on transparency, compliance, and affordability, particularly targeting underserved markets such as the U.S. Latino population.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Panacea Life Sciences Holdings Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA25471) on November 18, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.